Opinion: Anticipating the Next Pandemic

Our experience with COVID-19 has already shone a light on how (and how not) to address future outbreaks.

Written byDebora MacKenzie
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, pinkomelet

There is still much science doesn’t know about COVID-19, and so it may seem the height of hubris to write a book about the pandemic now. But I just did—and in researching and writing COVID-19, I found we can largely answer several important questions already.

How did the pandemic start? SARS-CoV-2 most likely jumped to people from bats—a virus already able to infect and replicate in human cells. Could we have stopped the pandemic? Our best chance would have been to stop it before it started: we could have done far more to prevent humans from catching viruses from bats. It can be done. Bats in the US carry rabies, for example, but human cases are vanishingly rare because, left to their own devices, the two rarely encounter each other.

Scientists have been warning of a zoonotic pandemic for decades. And many caution that there will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

July/August 2020

Life During a Pandemic

Understanding the virus is just the beginning

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies